Repolarization variability in the risk stratification of MADIT II patients

Europace

Volumn 9, Issue 9, 2007, Pages 717-723

  Couderc, Jean Philippe ^a   Zareba, Wojciech ^a   McNitt, Scott ^a   Maison Blanche, Pierre ^b,c   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HÔPITAL LARIBOISIÈRE   (France)

^c Ela Medical SA   (France)

Author keywords

MADIT II; Risk stratification; T wave variability

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; T WAVE;

AGED; ALGORITHMS; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 34548501299     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum131     Document Type: Article

References (29)

1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98: 2334-51.
2. Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB et al. Clinical and economic implications of the Multicenter Automatic Defibrillator implantation Trial-II. Ann Intern Med 2005;142:593-600.
3. Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R et al. The cost-effectiveness of automatic implantable cardiac defibrillators: Results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation 1998;97:2129-35.
4. Jauhar S, Slotwiner DJ. The economics of ICDs. N Engl J Med 2004;351: 2542-4.
5. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004; 110:1885-9.
6. Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: Prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998;9:1258-68.
7. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical atternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994;330:235-41.
8. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004; 44:1481-7.
9. Verrier RL, Nearing BD. Ambulatory ECG monitoring of T-wave alternans for arrhythmia risk assessment. J Electrocardiol 2003;36 193-7.
10. Verrier RL, Nearing BD, La Rovere MT, Pinna GD, Mittleman MA, Bigger JT Jr et al. Ambulatory electrocardiogram-based tracking of Twave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 2003;14:705-11.
11. Verrier RL, Kwaku KF, Nearing BD, Josephson ME. T-wave altermans: Does size matter. J Cardiovasc Electrophysiol 2005;16:625-8.
12. Verrier RL, Nearing BD, Kwaku KF. Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave altermans analysis: evidence and methodological guidelines. Ann Noninvasive Electrocardiol 2005;10: 110-20.
13. Zareba W, Couderc JP, Burratini L. T wave altermans and T wave variability: Noninvasive indices of vulnerability to ventricular tachyarrhythmias. In: Zareba W, Maison-Blanche P, Locati-Heilbron E, ed. Noninvasive Electrocardiology in Clinical Practice. Armonk, NY: Futura Publishing Company, Inc; 2001. p 123-43.
14. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-65.
15. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004; 44:1481-7.
16. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-83.
17. Zareba W, Steinberg J, McNitt S, Daubert JP, Plotrowicz K, Moss AJ. ICD therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm J. 2006;3 631-7.
18. Zareba W, Locati E, Maison-Blanche P. The ISHNE Holter standard output file format: A step toward compatibility of Holter systems. Ann Noninvasive Electrocardiol 1998;3:261-2.
19. Couderc JP, Zareba W, Burattini L, Konecki JA, Moss AJ. Beat-to-beat repolarization variability in amplitude and duration in LQTS patients with the SCN5A sodium channel gene mutation. J Electrocardiol 1998; 31:134.
20. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-65.
21. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: Results from a prospective observational study. J Am Coll Cardiol 2003; 41:2220-4.
22. Armoundas AA, Tomaselli GF, Esperer HD. Pathophysiological basis and clinical application of T-wave altermans. J Am Coll Cardiol 2002;b40:207-17.
23. Rashba EJ, Cooklin M, Macmurdy K, Kavesh N, Kirk M, Sarang S et al. Effects of selective autonomic blockade on T-wave altermans in humans. Circulation 2002;105:837-42.
24. Burattini L, Zareba W. Time-domain analysis of beat-to-beat variability of repolarization morphology in patients with ischemic cardiomyopathy. J Electrocardiol 1999;32:166-72.
25. Halgney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S et al. QT Interval Variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004; 44:1481-7.
26. Burattini L, Zareba W, Rashba EJ, Couderc JP, Konecki J, Moss AJ. ECG features of microvolt T-wave alternans in coronary artery disease and long QT syndrome patients. J Electrocardiol 1998;31:114-20.
27. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S et al. QT Interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004; 44:1481-7.
28. Couderc JP, Zareba W, Burattini L, Moss AJ. Beat-to-beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation. Pacing Clin Electrophysiol 1999;22:1581-92.
29. Verrier RL, Nearing BD, La Rovere MT, Pinna GD, Mittleman MA, Bigger JT Jr et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J. Cardiovasc Electrophysiol 2003;14:705-11.